This document provides interim guidance to laboratories and other stakeholders involved in
diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It covers …

Diagnostic testing for SARS-CoV-2 is a critical component to the overall prevention and
control strategy for COVID-19. Countries should have a national testing strategy in place …

Key Clinical Points Rapid Diagnostic Testing for SARS-CoV-2 Rapid diagnostic tests (RDTs)
that are authorized by the Food and Drug Administration to diagnose severe acute …

The diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
globally has relied extensively on molecular testing, contributing vitally to case identification …

IDSA Disclaimer As of the time of this publication, updates have been made to IDSA's
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …

Nearly 400,000 people worldwide are known to have been infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) beginning in December 2019. The virus …

A plethora of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic
tests are available, each with different performance specifications, detection methods, and …

Diagnostic testing plays a critical role in addressing the coronavirus disease 2019 (COVID-
19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV …

Laboratory-based diagnostic measures including virological and serological tests are
essential for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 and has quickly become a worldwide pandemic. In response, many …